News | August 25, 2022
Lupin to acquire brands Ondero and Ondero - Met from Boehringer Ingelheim
The cash consideration for the above acquisition will be Euro 26 million.
The cash consideration for the above acquisition will be Euro 26 million.
Company appoints five new independent directors to reconstituted board
The 562,000 square feet facility has been recognized as the first and largest integrated insulin manufacturer in Malaysia by MBR
The company is focused on therapies such as skinceuticals, gastroenterology, neuropsychiatry, cardiac diabetes care etc.
AstraZeneca and Indian Society of Nephrology aim to help clinicians and healthcare practitioners to provide holistic kidney care to their patients.
An outlay of Rs. 1,500 crore has been approved for strengthening/ up-gradation of these NIPERs for the period 2021-22 to 2025-26.
The funds raised in the seed round will be used for research and development of Shri Chyawan Ayurved Product
The expansion at CDMO facility in South Haven, will bring a new 4,000-gallon multi-use reactor train consisting of glass lined and stainless-steel materials of construction
MedTel aims to raise series A for rapid business expansion, product improvement & conducting relevant clinical validation studies.
An algorithm based testing for Fatty Liver Disease
Subscribe To Our Newsletter & Stay Updated
